Boehringer Ingelheim’s Jascayd blocks a protein involved in the lung inflammation that develops from idiopathic pulmonary fibrosis, a rare and ultimately fatal disease with few available therapies. The twice-daily pill doesn’t cure IPF but clinical trial results showed it slowed disease progression. The post Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder…
The speaker roster for the September 18 conference spans industry experts in cybersecurity, healthcare investment, AI for drug development, diagnostic testing, and more. The post Who is Speaking at MedCity INVEST Digital Health in Dallas? appeared first on MedCity News.
Merck’s HIV drug Idvynso could become a drug choice for patients who need to switch from Gilead Sciences’ Biktarvy for safety or tolerability reasons. The Merck combination drug pairs two molecules that bring different mechanisms of action to suppressing HIV. The post FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral…
Leaders in pharma’s AI age won’t be remembered for moving the fastest, but for earning and keeping trust along the way. Privacy will determine which companies pull ahead and which fall behind, making it one of the industry’s biggest tests. The post What Pharma Needs To Get Right About Privacy In The AI Age appeared…
Homeless shelters and FQHCs will begin using a common platform to improve care coordination
ECG Management Consultants’ Terri Welter says Medicaid presents a big opportunity to shift to value-based care, while the commercial insurers will probably be the last to do it
[Sponsored] Your varicose or spider veins may indicate an underlying problem, so finding the right vein specialist is crucial. Discover the best vein clinics in Orlando. The post Your Guide to the Best Vein Clinics in Orlando appeared first on MedCity News.
The FDA said consolidating safety reporting into a single platform, the Adverse Event Monitoring System (AEMS), will increase transparency and reduce costs. But like the legacy systems it replaces, AEMS reports are unverified so causation and frequency of events cannot be determined. The post FDA Transparency Push Expands to Monitoring Safety of Vaccines and Other…
Health policy changes in Washington will ripple through the country, resulting in millions of Americans losing their Medicaid or Affordable Care Act coverage. But there are still ways to find care. Over the next decade, the GOP’s One Big Beautiful Bill Act is expected to slash nearly $1 trillion in spending from Medicaid, the state-federal…
As the government shutdown continues, public support remains high for extending the enhanced ACA tax credits set to expire at the end of the year, with three quarters (74%) of the public in favor of extending them, a new KFF Health Tracking Poll finds.